Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adma Biologics (ADMA) Change in Acquisitions & Divestments: 2016-2017

Historic Change in Acquisitions & Divestments for Adma Biologics (ADMA) over the last 1 years, with Jun 2017 value amounting to $245,000.

  • Adma Biologics' Change in Acquisitions & Divestments rose 106.67% to $245,000 in Q2 2017 from the same period last year, while for Jun 2017 it was $18.4 million, marking a year-over-year change of. This contributed to the annual value of $5.4 million for FY2017, which is 67.64% down from last year.
  • Latest data reveals that Adma Biologics reported Change in Acquisitions & Divestments of $245,000 as of Q2 2017, which was down 95.24% from $5.1 million recorded in Q1 2017.
  • Over the past 5 years, Adma Biologics' Change in Acquisitions & Divestments peaked at $16.7 million during Q4 2016, and registered a low of -$3.7 million during Q2 2016.
  • For the 2-year period, Adma Biologics' Change in Acquisitions & Divestments averaged around $4.4 million, with its median value being $3.7 million (2016).
  • Data for Adma Biologics' Change in Acquisitions & Divestments shows a peak YoY spiked of 106.67% (in 2017) over the last 5 years.
  • Quarterly analysis of 2 years shows Adma Biologics' Change in Acquisitions & Divestments stood at $16.7 million in 2016, then skyrocketed by 106.67% to $245,000 in 2017.
  • Its Change in Acquisitions & Divestments stands at $245,000 for Q2 2017, versus $5.1 million for Q1 2017 and $16.7 million for Q4 2016.